HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1789762Generated: October 25, 2026
Sodium Hydroxide → 1-(4-Chloro-[1,2,5]thiadiazol-3-yl)piperazine hydrochloride
https://huagongshe.com/reaction/1789762
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | 3,4-Dichloro-1,2,5-thiadiazole | HCID 79804 | — |
| Reactant | Piperazine, hexahydrate | HCID 120181 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Sodium chloride; water | HCID 57417360 | — |
| Product | 1-(4-Chloro-[1,2,5]thiadiazol-3-yl)piperazine hydrochloride | HCID 21202042 | 89% |
Reaction Steps
A mixture of 3,4-dichloro-1,2,5-thiadiazole (4.00 g, 25.8 mmol) and piperazine hexahydrate (25.0 g, 130 mmol) in DMF (25 mL) was heated at 70° C. for 20 minutes. After cooling to ambient temperature, the reaction mixture was basified (11M NaOH) and brine was added. The resulting mixture was extracted with CHCl3 (×3). The combined organic phases were washed twice with brine/water (1:1), dried (MgSO4) and the solvent was evaporated. The resulting oil was purified by column chromatography on silica gel using CHCl3 as eluent to give 2.77 g (52%) of the title compound as a colourless oil which was converted to its hydrochloride salt: mp 231° C. (dec). Anal. (C6H9CIN4S.HCl), calc 29.89, found 30.4. H, N.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07071180B2 |
|---|
| Source dataset | uspto-grants-2006_07 |
|---|
| ORD ID | ord-3555db0f151642c7b45cc764313fca0f |
|---|
| Source note | uspto-grants-2006_07 |
|---|